Brind.

MaxCyte, Inc. Lists on Nasdaq Amid Institutional Buying and Earnings Outlook

2 reports, 2 independent Updated 00:00
Still developing Reached 2 outlets in its first 24 hours
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below and has updated it as the story developed. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

MaxCyte, Inc. officially listed its shares on the Nasdaq exchange on November 3, 2026. Following the listing, an Ohio retirement system purchased MaxCyte shares on November 4, 2026. Reports also indicate that Susquehanna International Group LLP boosted its stake in MaxCyte shares by 277.5% during the second quarter.

From tickerreport.com, dailypolitical.com

Why it matters

Some supportBrind's analysis of the reports

The listing and subsequent market activity provide context for MaxCyte, Inc.'s valuation, which currently stands at a market cap of $145.00 million. Analysts expect MaxCyte to post Q3 2026 earnings of ($0.08) per share, with revenue projected at $7.39 million.

From dailypolitical.com

Who's involved

  • NasdaqThe American stock exchange where MaxCyte, Inc. is listed.
  • MarketBeatA personal finance blog that provided a consensus rating for MaxCyte, Inc.

How it developed

Newest first. Tap a step to see who reported it.
  1. Ohio retirement system bought MaxCyte shares and MarketBeat provided a consensus rating.1 source
  2. MaxCyte, Inc. officially listed its shares on the Nasdaq exchange.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped